Diagnosis-Day Prothrombin Time and Transaminase as Exploratory Risk-Stratification Indicators for Severe Neonatal Outcomes in Acute Fatty Liver of Pregnancy
Gynecologic and Obstetric Investigation · 12.10.2026 · 1-1
DOI: 10.1159/goi/aczag013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gynecologic and Obstetric Investigation, online erschienen am 12.10.2026. Verfasst von Dong Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objectives
Acute fatty liver of pregnancy (AFLP) is a life-threatening condition associated with high neonatal morbidity. This study aimed to conduct an exploratory risk-stratification analysis using diagnosis-day laboratory indicators to assess severe adverse neonatal outcomes (SANOs).
Methods
In this single-center retrospective cohort (2004–2021), 18 pregnancies with AFLP confirmed by Swansea criteria were analyzed. Firth-penalized logistic regression assessed associations between the first laboratory values on the diagnosis day and SANO (intrauterine death/severe asphyxia). Minimal two-variable models combining prothrombin time (PT) with total bilirubin or peak transaminase were evaluated. Model performance was summarized using the area under the receiver operating characteristic curve (AUC), leave-one-out cross-validation (LOOCV), and descriptive temporal sensitivity analysis.
Results
The incidence of AFLP was 0.71 per 10,000 pregnancies. At the pregnancy level, SANO occurred in 4 of 18 pregnancies (22.2%). Diagnosis-day coagulopathy, especially prolonged PT, was the most prominent associated marker. The PT + Peak transaminase model yielded an apparent AUC of 0.982 and a LOOCV AUC of 0.964, but these estimates require cautious interpretation because only 4 SANO events were available. The descriptive temporal sensitivity analysis showed 2 SANO events in both 2004–2012 and 2013–2021.
Conclusions
Coagulation dysfunction at diagnosis may serve as an exploratory indicator of neonatal risk in AFLP. The proposed PT-centered framework should be interpreted as a hypothesis-generating risk-stratification signal that requires external validation before clinical use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Obstetrics, Sanmen People's Hospital, Sanmenwan Branch, The First Affiliated Hospital, College of Medicine, Zhejiang University, Taizhou, China.
- Department of Obstetrics, Shaoxing Shangyu Maternal and Child Health Hospital, Shaoxing, China.
- Department of Obstetrics, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China, zhaobh@zju.edu.cn.
Zitieren
APA
Xu, D., Jiang, P., Chen, H., Shao, L., & Zhao, B. (2026). Diagnosis-Day Prothrombin Time and Transaminase as Exploratory Risk-Stratification Indicators for Severe Neonatal Outcomes in Acute Fatty Liver of Pregnancy. Gynecologic and Obstetric Investigation, 1-1. https://doi.org/10.1159/goi/aczag013
Vancouver
Xu D, Jiang P, Chen H, Shao L, Zhao B. Diagnosis-Day Prothrombin Time and Transaminase as Exploratory Risk-Stratification Indicators for Severe Neonatal Outcomes in Acute Fatty Liver of Pregnancy. Gynecologic and Obstetric Investigation. 2026:1-1. doi:10.1159/goi/aczag013
BibTeX
@article{Xu2026,
author = {Xu, Dong and Jiang, Peiyue and Chen, Hong and Shao, Lihua and Zhao, Baihui},
title = {Diagnosis-Day Prothrombin Time and Transaminase as Exploratory Risk-Stratification Indicators for Severe Neonatal Outcomes in Acute Fatty Liver of Pregnancy},
journal = {Gynecologic and Obstetric Investigation},
year = {2026},
pages = {1--1},
doi = {10.1159/goi/aczag013}
}
EUVIMED